NCT04614103 2025-11-12Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung CancerIovance Biotherapeutics, Inc.Phase 2 Recruiting170 enrolled
NCT03645928 2025-06-19Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid TumorsIovance Biotherapeutics, Inc.Phase 2 Recruiting245 enrolled
NCT03419559 2019-04-16Study of Autologous Tumor Infiltrating Lymphocytes (LN-145) In Combo With Durvalumab in Non-Small Cell Lung CancerIovance Biotherapeutics, Inc.Phase 2 Withdrawn